Insights into substrate binding and utilization by hyaluronan synthase
Hyaluronan (HA), a heteropolysaccharide of alternating <i>N</i>-acetylglucosamine (GlcNAc) and glucuronic acid (GlcA), is an essential component of the vertebrate extracellular matrix. HA biosynthesis proceeds via three evolutionarily convergent reaction mechanisms, catalyzed by the membrane-integrated class 1 enzymes that either elongate the non-reducing (NR) or reducing end of HA, as well as the class 2 hyaluronan synthase (HAS), a soluble non-processive enzyme. Class 1-NR HAS, found in both vertebrates and large double-stranded DNA viruses, is monomeric and couples HA polymerization via coordinated transfer of UDP-GlcNAc and UDP-GlcA substrates with the secretion of the nascent HA chain through its own transmembrane channel. How this HAS discriminates between two UDP-sugars using a single active site is a critical, yet unresolved question. Using single-particle cryo-EM, we reveal a two-step process by which the <i>Chlorella</i> virus HAS (CvHAS) recognizes and positions its substrate, UDP-GlcA, for glycosyl transfer. Further, we report greatly diminished turnover of UDP-GlcA in the absence of a primer, distinguishing acceptor-free activity toward UDP-GlcNAc. Lastly, prompted by observation of a dodecyl maltoside bound HAS, we demonstrate the utility of non-canonical acceptors in priming of a UDP-GlcA transfer reaction. Altogether, this work clarifies the molecular basis for HAS' dual substrate specificity and the role of UDP-GlcA recognition in integrity of HA synthesis.
Authors
- Zachery Stephens (ORCID: https://orcid.org/0009-0001-0140-5304)
- Jochen Zimmer (ORCID: https://orcid.org/0000-0002-8423-2882)
- Julia Karasinska
Institutions
- Howard Hughes Medical Institute (US)
- ETH Zurich (CH)
- Institute of Molecular Biology and Biophysics (RU)
- University of Virginia (US)
Publication Details
- Journal
- eLife
- Published
- 2025-12-17
- DOI
- https://doi.org/10.7554/elife.109624
- Primary Topic
- Proteoglycans and glycosaminoglycans research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Howard Hughes Medical Institute
- National Institutes of Health